{"article": [{"url": "https://www.marketwatch.com/story/johnson-johnson-stock-rises-thursday-still-underperforms-market-01602188734", "published": 1602174800.0, "headline": "Johnson & Johnson stock rises Thursday, still underperforms market", "body": "Shares of Johnson & Johnson JNJ, +1.39% inched 0.68% higher to $148.89 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX, +0.87% rising 0.80% to 3,446.83 and the Dow Jones Industrial Average DJIA, +0.56% rising 0.43% to 28,425.51. This was the stock's second consecutive day of gains. Johnson & Johnson closed $8.11 below its 52-week high ($157.00), which the company reached on April 23rd. The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Roche Holding AG Part. Cert. RHHVF, +2.93% fell 0.73% to $341.00, Merck & Co. Inc. MRK, -0.14% rose 0.55% to $80.48, and Pfizer Inc. PFE, -0.27% rose 1.15% to $36.89. Trading volume (4.3 M) remained 1.5 million below its 50-day average volume of 5.8 M. Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use."}]}